Pharmaceutical Industry in India, Share, Size, Companies,
India Pharmaceutical Market
The latest report by IMARC Group, titled, “India Pharmaceutical Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” offers a comprehensive analysis of the industry, which comprises insights on the India Pharmaceutical Market. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The Indian pharmaceutical market size reached US$ 48.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 102.7 Billion by 2028, exhibiting a growth rate (CAGR) of 13.01% during 2023-2028.
Get a Free Sample Copy of the Report at – https://www.imarcgroup.com/india-pharmaceutical-market/requestsample
The pharmaceutical industry is a critical sector dedicated to the research, development, manufacturing, and distribution of medications and healthcare products. It plays a pivotal role in maintaining and improving public health worldwide. Pharmaceutical companies are at the forefront of scientific research, investing heavily in discovering and developing new drugs and therapies to treat and prevent a wide range of diseases and medical conditions.
This research involves rigorous testing and clinical trials to ensure the safety and efficacy of medications. Pharmaceuticals also encompass over the counter (OTC) medications, vaccines, biologics, and medical devices, all of which contribute to healthcare advancements. Pharmacists and healthcare professionals play a vital role in dispensing medications and providing valuable information to patients regarding proper usage and potential side effects.
Industry Growth:
The pharmaceutical market in India is majorly driven by the increasing burden of diseases, a growing aging population, and rising healthcare awareness among Indians. As healthcare infrastructure and access to medical facilities improve, more patients are seeking prescription medications and healthcare services, fueling pharmaceutical sales.
Moroever, the government’s initiatives to promote domestic pharmaceutical manufacturing have incentivized pharmaceutical companies to invest in research and development and expand their production capacities. This has led to a diversified product portfolio and increased competitiveness in the global market. India’s regulatory environment has also undergone significant improvements to align with international standards, enhancing the country’s reputation as a reliable pharmaceutical manufacturer.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/india-pharmaceutical-market
Competitive Landscape with Key Players:
• Abbott India Limited (Abbott Laboratories)
• Aurobindo Pharma Limited
• Biocon Limited
• Cadila Pharmaceuticals Limited (CPL)
• Cipla Limited
• Divi’s Laboratories Limited
• Reddy’s Laboratories Ltd.
• GlaxoSmithKline Pharmaceuticals Limited (GSK plc)
• Lupin Limited
• Mankind Pharma Ltd.
• Merck India Private Limited
• Novartis India Limited (Novartis AG)
• Pfizer Healthcare India Pvt. Ltd. (Pfizer Inc.)
• Sun Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd. (Torrent Group)
India Pharmaceutical Market 2023-2028 Analysis and Segmentation:
Breakup by Type:
• Pharmaceutical Drugs
o Cardiovascular Drugs
o Dermatology Drugs
o Gastrointestinal Drugs
o Genito-Urinary Drugs
o Hematology Drugs
o Anti-Infective Drugs
o Metabolic Disorder Drugs
o Musculoskeletal Disorder Drugs
o Central Nervous System Drugs
o Oncology Drugs
o Ophthalmology Drugs
o Respiratory Diseases Drugs
• Biologics
o Monoclonal Antibodies (MAbS)
o Therapeutic Proteins
o Vaccines
Breakup by Nature:
• Organic
• Conventional
Breakup by Region:
• North India
• West and Central India
• South India
• East India
Key Highlights of the Report:
• Market Performance
• Market Outlook
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high-technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology, and novel processing methods are at the top of the company’s expertise.
This release was published on openPR.
No Byline Policy
Editorial Guidelines
Corrections Policy
Source